Fenton-like degradation of MTBE: Effects of iron counter anion and radical scavengers.
Sangchul Hwang, Scott G Huling, Saebom Ko
Index: Chemosphere 78(5) , 563-8, (2010)
Full Text: HTML
Abstract
Fenton-driven oxidation of methyl tert-butyl ether (MTBE) (0.11-0.16mM) in batch reactors containing ferric iron (5mM) and hydrogen peroxide (H(2)O(2)) (6mM) (pH=3) was performed to investigate MTBE transformation mechanisms. Independent variables included the forms of iron (Fe) (Fe(2)(SO(4))(3).9H(2)O and Fe(NO(3))(3).9H(2)O), H(2)O(2) (6, 60mM), chloroform (CF) (0.2-2.4mM), isopropyl alcohol (IPA) (25, 50mM), and sulfate (7.5mM). MTBE, tert-butyl alcohol and acetone transformation were significantly greater when oxidation was carried out with Fe(NO(3))(3).9H(2)O than with Fe(2)(SO(4))(3).9H(2)O. Sulfate interfered in the formation of the ferro-peroxy intermediate species, inhibited H(2)O(2) reaction, hydroxyl radical (()OH) formation, and MTBE transformation. Transformation was faster and more complete at a higher [H(2)O(2)] (60mM), but resulted in lower oxidation efficiency which was attributed to ()OH scavenging by H(2)O(2). CF scavenging of the superoxide radical (()O(2)(-)) in the ferric nitrate system resulted in lower rates of ()O(2)(-) reduction of Fe(III) to Fe(II), ()OH production, and consequently lower rates of MTBE transformation. IPA, an excellent scavenger of ()OH, completely inhibited MTBE transformation in the ferric nitrate system indicating oxidation was predominantly by ()OH. ()OH scavenging by HSO(4)(-), formation of the sulfate radical (()SO(4)(-)), and oxidation of MTBE by ()SO(4)(-) was estimated to be negligible. The form of Fe (i.e., counter anion) selected for use in Fenton treatment systems impacts oxidative mechanisms, treatment efficiency, and post-oxidation treatment of residuals which may require additional handling and cost.2009 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
2014-01-01
[Nanoscale Res. Lett. 9(1) , 510, (2014)]
2015-02-01
[Toxicol. Appl. Pharmacol. 282(3) , 237-43, (2015)]
A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
2012-02-14
[Int. J. Pharm. 423(1) , 16-25, (2012)]
An unprecedented Fe(36) phosphonate cage.
2015-07-01
[Inorg. Chem. 52(4) , 1670-2, (2013)]
2005-06-01
[Oral Microbiol. Immunol. 20(3) , 147-53, (2005)]